Fig. 3From: Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulatorsRepresentative scheme of possible neoantigens determination and validation procedure. Healthy and tumor cells comparative RNA sequencing will be performed, with the use of sophisticated software a complete analysis for neoantigen prediction will be done, continuing with an in vitro validationBack to article page